ICU Medical vs Envista Holdings
Envista Holdings is the larger business, with $2.72bn of revenue in fiscal 2025 against $2.23bn for ICU Medical (1.2 times as much). Envista Holdings grew faster (8.3% against -6.3%). Envista Holdings kept more of each dollar of sales as profit: a net margin of 1.7% against 0.0%.
| Latest fiscal year | ICU MedicalICUI, 2025 | Envista HoldingsNVST, 2025 |
|---|---|---|
| Revenue | $2.23bn | $2.72bn |
| Revenue growth | -6.3% | 8.3% |
| Net income | $732,000 | $47.0m |
| Operating margin | — | 7.9% |
| Net margin | 0.0% | 1.7% |
| Return on equity | 0.0% | 1.6% |
| Free cash flow | $91.8m | $230m |
| Cash | $308m | $1.21bn |
| Total debt | $1.29bn | $1.46bn |
| Debt to equity | — | 47.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $8.8m | $167m |
| Employees | 13,000 | 12,700 |
| Market value | $4.03bn | $3.98bn |
| Price vs our value range | Above our value range | Within our value range |
| Moat score | 35 (Weak) | 48 (Moderate) |
| Insider trades, 12 months | 0 buys, 19 sales | 0 buys, 3 sales |